GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Illumina ILMN · USD

Health Care · US listing · 🇺🇸 United States

S&P 500

Compare

200.66

-4.45%

Close of 19 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Illumina — daily ILMN Delayed
Market value
$31.30bn
Last close × shares
Volume
1.6m
Shares, 19 Nov 2026
Price to earnings
41.6

About Illumina

From its filings with the US Securities and Exchange Commission

SEC filings

Illumina is based in San Diego, California and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker ILMN. It is a member of the S&P 500. The SEC classifies its business as laboratory analytical instruments. In the fiscal year to 28 December 2025, it reported revenue of $4.34bn and net income of $850.0m. At that date it held total assets of $6.64bn and shareholders' equity of $2.72bn.

Read the filing on SEC.gov ↗

More about Illumina →

How it makes its money

Revenue, year to 28 Dec 2025

  • Product $3.71bn · 85.4%
  • Consumables $3.23bn · 74.3%
  • Service $634.0m · 14.6%
  • Instruments $482.0m · 11.1%

Latest on Illumina

Our reporting

Next results

4 Feb 2027

Due on 4 Feb 2027. Analysts expect earnings of 1.52 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Illumina's ticker?

Illumina trades as ILMN on its US listing, under ISIN US4523271090.

What was Illumina's last closing price?

200.66 on 19 Nov 2026. The figure is in USD and is never converted.

When does Illumina next report results?

Results are expected on 4 Feb 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
SEC filings and our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.